Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1007, doi. 10.1002/cpdd.831
- Publication type:
- Article
Works matching IS 2160763X AND DT 2022 AND VI 11 AND IP 9
Results: 13
1
2
A Randomized Thorough QT Study of Apomorphine Sublingual Film in Patients With Parkinson's Disease.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1068, doi. 10.1002/cpdd.1147
- By:
- Publication type:
- Article
3
A Randomized, Double‐Blind, Parallel Controlled, Single‐Dose Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of the Infliximab Biosimilar CMAB008 and the Reference Product in Healthy Chinese Male Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1028, doi. 10.1002/cpdd.1135
- By:
- Publication type:
- Article
4
Phase 1 Study Evaluating Pharmacokinetics and Tolerability of Ofatumumab Combined With Bendamustine in Patients With Indolent B‐Cell Non‐Hodgkin's Lymphoma.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1099, doi. 10.1002/cpdd.1133
- By:
- Publication type:
- Article
5
Population Pharmacokinetic/Pharmacodynamic Modeling of the Effect of Abrocitinib on QT Intervals in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1036, doi. 10.1002/cpdd.1111
- By:
- Publication type:
- Article
6
Clinical Formulation Bridging of Gefapixant, a P2X3‐Receptor Antagonist, for the Treatment of Chronic Cough.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1054, doi. 10.1002/cpdd.1105
- By:
- Publication type:
- Article
7
First‐in‐Human Single‐Ascending‐Dose, Multiple‐Dose, and Food Interaction Studies of NRD.E1, an Innovative Nonopioid Therapy for Painful Diabetic Peripheral Neuropathy.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1012, doi. 10.1002/cpdd.1103
- By:
- Publication type:
- Article
8
A Pharmacokinetic Bioequivalence Study Comparing Different‐Strength and ‐Size Capsules of Isavuconazonium Sulfate in Healthy Japanese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1092, doi. 10.1002/cpdd.1101
- By:
- Publication type:
- Article
9
Pharmacokinetics and Bioequivalence of 2 Azithromycin Tablet Formulations: A Randomized, Open‐Label, 2‐Stage Crossover Study in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1078, doi. 10.1002/cpdd.1098
- By:
- Publication type:
- Article
10
Pharmacokinetics and Bioequivalence of 2 Oral Formulations of Domperidone After Single‐Dose Administration in Healthy Chinese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1084, doi. 10.1002/cpdd.1097
- By:
- Publication type:
- Article
11
Pharmacokinetics and Bioequivalence of a Generic and a Branded Pazopanib Tablet in Healthy Chinese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1110, doi. 10.1002/cpdd.1096
- By:
- Publication type:
- Article
12
Effect of Food Intake on Pharmacokinetics of Oral Almonertinib: A Randomized Crossover Trial in Healthy Chinese Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1046, doi. 10.1002/cpdd.1095
- By:
- Publication type:
- Article
13
Comparative Pharmacokinetics, Safety, and Immunogenicity Study of the Prefilled Syringe and Lyophilized Formulation of a Recombinant Human Tumor Necrosis Factor‐α Receptor II:lgG Fc Fusion Protein in Healthy Chinese Male Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1116, doi. 10.1002/cpdd.1091
- By:
- Publication type:
- Article